BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bi Y, Cui D, Xiong X, Zhao Y. The characteristics and roles of β-TrCP1/2 in carcinogenesis. FEBS J 2021;288:3351-74. [PMID: 33021036 DOI: 10.1111/febs.15585] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Paul D, Kales SC, Cornwell JA, Afifi MM, Rai G, Zakharov A, Simeonov A, Cappell SD. Revealing β-TrCP activity dynamics in live cells with a genetically encoded biosensor. Nat Commun 2022;13:6364. [PMID: 36289220 DOI: 10.1038/s41467-022-33762-3] [Reference Citation Analysis]
2 Srivastava R, Fernández-Ginés R, Encinar JA, Cuadrado A, Wells G. The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance. Free Radic Biol Med 2022:S0891-5849(22)00605-0. [PMID: 36181972 DOI: 10.1016/j.freeradbiomed.2022.09.023] [Reference Citation Analysis]
3 Huang S, Zhong J, Qi Q, Liu G, Gong M. CircRNA expression profile and potential role of hsa_circ_0040039 in intervertebral disc degeneration. Medicine (Baltimore) 2022;101:e30035. [PMID: 35960109 DOI: 10.1097/MD.0000000000030035] [Reference Citation Analysis]
4 Xia L, Chen J, Huang M, Mei J, Lin M. The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression. Front Oncol 2022;12:963617. [DOI: 10.3389/fonc.2022.963617] [Reference Citation Analysis]
5 Yuan T, Zhou T, Qian M, Du J, Liu Y, Wang J, Li Y, Fan G, Yan F, Dai X, Li X, Wu Y, Dong X, He Q, Zhu H, Yang B. SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ. Hepatology 2022. [PMID: 35713976 DOI: 10.1002/hep.32621] [Reference Citation Analysis]
6 Bano I, Malhi M, Zhao M, Giurgiulescu L, Sajjad H, Kieliszek M. A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy. 3 Biotech 2022;12:103. [PMID: 35463041 DOI: 10.1007/s13205-022-03162-x] [Reference Citation Analysis]
7 Wei P, Jiang J, Xiao M, Zeng M, Liu X, Zhao B, Chen F. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation. Exp Cell Res 2022;412:113009. [PMID: 34990616 DOI: 10.1016/j.yexcr.2022.113009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ye P, Chi X, Cha JH, Luo S, Yang G, Yan X, Yang WH. Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges. Cells 2021;10:3309. [PMID: 34943817 DOI: 10.3390/cells10123309] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Ma Y, Cui D, Wang L, Wang Y, Yang F, Pan H, Gong L, Zhang M, Xiong X, Zhao Y. P90 ribosomal S6 kinase confers cancer cell survival by mediating checkpoint kinase 1 degradation in response to glucose stress. Cancer Sci 2021. [PMID: 34668620 DOI: 10.1111/cas.15168] [Reference Citation Analysis]
10 Wang D, Zhang Y, Xu X, Wu J, Peng Y, Li J, Luo R, Huang L, Liu L, Yu S, Zhang N, Lu B, Zhao K. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3. Nat Commun 2021;12:2674. [PMID: 33976226 DOI: 10.1038/s41467-021-22987-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]